Cell adhesion molecules in bladder cancer: Soluble serum E-cadherin correlates with predictors of recurrence

British Journal of Cancer

Volumn 74, Issue 4, 1996, Pages 579-584

  Griffiths, T R L ^a,b   Brotherick, I ^b   Bishop, R I ^c   White, M D ^b   McKenna, D M ^c   Horne, C H W ^c   Shenton, B K ^b   Neal, D E ^a,b   Mellon, J K ^b,d  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bladder neoplasm; Cell adhesion molecule; Enzyme linked immunosorbent assay; Immunohistochemistry

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0029736969     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.404     Document Type: Article

References (32)

1. ALTHAUSEN AF, PROUT GR AND DALY JJ. (1976). Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116, 575 - 580.
2. BANKS RE, GEARING AJH, HEMINGWAY IK, NORFOLD DR, PERSEN TJ AND SELBY PJ. (1993). Circulating intercellular adhesion molecule-1 (ICAM-1). E-selectin, and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br. J. Cancer, 68, 122 - 124.
3. BANKS RE, PORTER WH, WHELAN P, SMITH PH AND SELBY PJ. (1995). Soluble forms of the adhesion molecule E-cadherin in urine. J. Clin. Pathol., 48, 179 - 180.
4. BECKER JC, DUMMER R, SCHWINN A, HARTMANN AA AND BURG G. (1992). Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. J. Immunother., 12, 147 - 150.
5. BEHRENS J, BICHMEIER W, GOODMAN SL AND IMHOF BA. (1985). Dissociation of Modin-Party canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J. Cell Biol., 101, 1307 - 1315.
6. BRINGUIER PP, UMBAS R, SCHAAFSMA HE, KARTHAUS HF, DEBRUYNE FM AND SCHALKEN JA. (1993). Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumours. Cancer Res., 53, 3241 - 3245.
7. GREENE LF, HANASH KA AND FARROW GM. (1973). Benign papilloma or papillary cancer of the bladder. J. Urol., 110, 205 - 207.
8. HARNING R, MAINOLFI E, BYSTRYN JC, HENN M, MERLAZZI VJ AND ROTHLEIN R. (1991). Serum levels of circulating intercellular adhesion molecule-1 in human malignant melanoma. Cancer Res., 51, 5003 - 5005.
9. KATAYAMA M, HIRAI S, KAMIHAGI K, NAKAGAWA K, YASUMOTO M AND KATO I. (1994). Soluble E-cadherin fragments increased in circulation of cancer patients. Br. J. Cancer, 69, 580 - 585.
10. KOCH AE, HALLORAN MM, HASKELL CJ, SHAH MR AND POLVERINI PJ. (1995). Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature, 376, 517 - 519.
11. LAURI D, NEEDHAM LA, MARTIN-PADURA I AND DEJANA E. (1991). Tumour cell adhesion to endothelial cells: endothelial leucocyte adhesion molecule-1 as an inducible receptor specific for colon carcinoma cells. J. Natl Cancer Inst., 83, 1341 - 1344.
12. LIPPONEN PK AND ESKELINEN MJ. (1995). Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J. Cancer Res. Ciln. Oncol., 121, 303 - 308.
13. LUNEC J, CHALLEN C, WRIGHT C, MELLON K AND NEAL DE (1992). Amplification of c-erbB-2 gene and mutation of p53 in concomitant transitional carcinoma of renal pelvis and urinary bladder. Lancet, 339, 439 - 440.
14. LUTZEYER W, RÜBBEN H AND DAHM M. (1982). Prognostic parameters in superficial bladder cancer: An analysis of 315 cases. J. Urol., 127, 250 - 252.
15. MOSTOFI FK. (1974). International histologic classification of tumours. A report by the Executive Committee of the International Council of Societies of Pathology. Cancer. 33, 1480 - 1504.
16. NAGAFUCHI A AND TAKEICHI M. (1988). Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J., 7, 3679 - 3684.
17. NATALI P, NICOTRA MR, CAVALIERE E, BIGOTTI A, ROMANO G, TEMPONI M AND FERRONE S. (1990). Differential expression of intercellular adhesion molecule-1 in primary and metastatic melanoma lesions. Cancer Res., 50, 1271 - 1278.
18. OOSTERLINCK W, KURTH KH, SCHRÖDER F, BULTINCK J, HAMMOND B AND SYLVESTER R. (1993). A prospective European Organisation for Research and Treatment of Cancer Genitourinary Group randomised trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, Tl papillary carcinoma of the bladder. J. Urol., 149, 749 - 752.
19. OTTO T, BICHMEIER W, SCHMIDT U, HINKE A, SCHIPPER J, RÜBBEN H AND RAZ A. (1994). Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res., 54, 3120 - 3123.
20. PARMAR MKB, FREEDMAN LS, HARGREAVE TB AND TOLLEY DA. (1989). Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: Report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J. Urol., 142, 284 - 287.
21. READING J, HALL RR AND PARMAR MKB. (1995). The application of a prognostic factor analysis for Ta.Tl bladder cancer in routine urological practice. Br. J. Urol., 75, 604 - 607.
22. REBEL JMJ, THIJSSEN CDEM, VERMEY M, DELOUVÉE A, ZWARTHOFF FC AND VAN DER KWAST TH. (1994). E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells. Cancer Res., 54, 5488 - 5492.
23. RICE GE AND BEVILACQUA MP. (1989). An inducible endothelial cell surface glycoprotein mediates adhesion. Science, 246, 1303-1306.
24. SHIMOYAMA Y, HIROHASHI S, HIRANO S, NOGUCHI M, SHIMOSATO Y, TAKEICHI M AND ABE O. (1989). Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res., 49, 2128 - 2133.
25. SIDRANKSY D, FROST P, VON ESCHENBACH A, OYASU R, PREISINGER AC AND VOGELSTEIN B. (1992). Clonal origins of metachronous tumours of the bladder. N. Engl. J. Med., 326, 737 - 740.
26. SMITH G, ELTON RA, CHISHOLM GD, NEWSHAM JE AND HARGREAVE TB. (1986). Superficial bladder cancer: Intravesical chemotherapy and tumour progression to muscle invasion or metastases. Br. J. Urol., 58, 659 - 663.
27. TAKEICHI M. (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251, 1451 - 1455.
28. TOLLEY DA, HARGREAVE TB, SMITH PH, WILLIAMS JL, GRIGOR KM, PARMAR MKB, FREEDMAN LS AND USCINSKA BM. (1988). Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br. Med. J., 296, 1759 - 1761.
29. TSUJISAKI M, IMAI K, HIRATA H, HANZAWA Y, MASUYA J, NAKANO T, SUGIYAMA T, MATSUI M, HINODA Y AND YACHI A. (1991). Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin. Exp. Immunol., 85, 3 - 8.
30. UMBAS R, SCHALKEN JA, AALDERS TW, CARTER BS, KARTHAUS HFM, SCHAAFSMA HE AND DEBRUYNE FMJ. (1992). Decreased expression of E-cadherin in high grade prostate cancer. Cancer Res., 52, 5104 - 5109.
31. UNION INTERNATIONALE CONTRE LE CANCER. (1992). The TNM Classification of Tumours, 1992. U.I.C.C.: Geneva.
32. WHEELOCK MJ, BUCK CA, BECHTOL KB AND DAMSKY CH. (1987). Soluble 80 kd fragment of cell-CAM 120/80 disrupts cell cell adhesion. J. Cell. Biochem., 34, 187-202.